Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development.
Cancer Immunol Res
; 7(8): 1244-1257, 2019 08.
Article
in En
| MEDLINE
| ID: mdl-31213474
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Apolipoproteins E
/
Membrane Glycoproteins
/
Receptors, Immunologic
/
T-Lymphocytes
/
Leukemia, Myeloid, Acute
/
Cell Transformation, Neoplastic
/
Antineoplastic Agents, Immunological
Limits:
Animals
/
Humans
Language:
En
Journal:
Cancer Immunol Res
Year:
2019
Document type:
Article